DUBLIN, Nov. 30, 2022 /PRNewswire/ -- The "Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography" report has been added to ResearchAndMarkets.com's offering.
The insulin market is projected to grow from US$ 54,611.42 million in 2021 to US$ 111,213.73 million by 2028. It is expected to grow at a CAGR of 10.8 % from 2022 to 2028. The increase in the incidence of diabetes and rapid technological developments in insulin delivery devices by major players is expected to bolster the insulin market in the years to come. Additionally, the regeneration of the diabetic pancreas with advanced transplants is likely to emerge as a significant future trend in the insulin market from 2022 to 2028. However, the risks associated with insulin delivery devices hamper the overall market growth. In diabetic people, the pancreas does not produce enough insulin, or the body does not usually respond to the insulin, increasing the blood glucose level. Insulin is a hormone that helps in lowering blood sugar levels. Insulin therapy is often an essential part of diabetes treatment. It is made by the beta cells of the pancreas and released into the blood when glucose levels rise, for example, after eating. Insulin helps glucose get into the body cells, which can be used for energy or stored for future use. Different types of insulin available vary in how quickly and for how long they can control blood sugar. Insulin does not come in pill form as the digestive system would break it down before it could work. Insulin therapy is exhausting; however, it is an effective way of lowering blood sugar levels. Products with advanced insulin technology with more benefits are a major requirement in treating diabetes. There has been a rise in advancements in diabetes treatment over the past few years. As the prevalence of diabetes is increasing worldwide, the demand for advanced products is also boosting. The insulin market is expected to grow owing to an increase in the strategic efforts made by the industry players. The market players actively support their public and private research and academic institutes for increasing research activities. A few of the recent developments related to rapid technological advancement in the insulin market are mentioned below:
2. Insulin Market - Key Takeaways
4. Insulin Market - Market Landscape
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South & Central America- PEST Analysis
5. Insulin Market- Key Market Dynamics
5.1.2 Rapid Technological Developments in Insulin Delivery Devices by Major Players
5.2.1 Risks Associated with Insulin Delivery Devices
5.3.1 Insufficient Competition from Biosimilars
5.4.1 Regeneration of Diabetic Pancreas with Advanced Transplants
6.1 Global Insulin Market Revenue Forecast and Analysis
6.1.1 Global Insulin Market, By Geography - Forecast and Analysis
6.1.2 Global Insulin Market - Market Potential Analysis, By Region
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.3.1 Market Share Analysis by Company
6.3.2 Market Share by Injectable GLPs
7. Insulin Market Analysis - By Type
7.2 Insulin Market Revenue Share, by Type (2021 and 2028)
7.3.2 Long Acting Insulin: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.3.2.1.2 Levemir: Insulin Market - Revenue and Forecast to 2028 (US$ Million) 7.3.2.2.2 Lantus: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.3.2.3.2 Basaglar: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.3.2.4.2 Tresiba: Insulin Market - Revenue and Forecast to 2028 (US$ Million) 7.4 Rapid Acting Insulins 7.4.2 Rapid Acting Insulins: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.1.2 Novolog: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.2.2 Humalog: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.3.2 Admelog: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.4.2 Others: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2 Short Acting Insulins and Traditional Human Insulins: Insulin Market - Revenue and Forecast to 2028 (US$ Million) 7.5.2.1.2 Novolin R: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.2.2 Humulin R: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.3.2 Insuman: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.4.2 Others: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Concentrated Insulins and Combination Insulins
7.6.2 Concentrated Insulins and Combination Insulins: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.1.2 NovoMix: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.2.2 Ryzodeg: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.3.2 Xultophy: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.4.2 Soliqua/Suliqua: Insulin Market - Revenue and Forecast to 2028 (US$ Million) 7.7.2 Biosimilar Insulins: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.7.2.1.2 Insulin Glargine: Insulin Market - Revenue and Forecast to 2028 (US$ Million) 7.7.2.2.2 Human Insulin: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Glucagon-like peptide-1 (GLP-1)
7.8.2 Glucagon-like peptide-1 (GLP-1): Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.9.2 Pens and Needles: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
7.10.2 Others: Insulin Market - Revenue and Forecast to 2028 (US$ Million)
8. Global Insulin Market - Geographic Analysis
10. Insulin Market-Industry Landscape
10.2 Growth Strategies in the Insulin Market (%)
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
For more information about this report visit https://www.researchandmarkets.com/r/26vmt8
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg